New Horizons for the Therapeutic Application of Nanozymes in Cancer Treatment

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2025 Feb 20

PMID 39979897

Authors

Pravanjan Malla

Yu-Ming Wang

Chia-Hao Su

Affiliations

Soon will be listed here.

Abstract

The advent of nanozymes has revolutionized approaches to cancer diagnosis and therapy, introducing innovative strategies that address the limitations of conventional treatments. Nanozyme nanostructures with enzyme-mimicking catalytic abilities exhibit exceptional stability, biocompatibility, and customizable functions, positioning them as promising tools for cancer theranostics. By emulating natural enzyme reactions, nanozymes can selectively target and eradicate cancer cells, minimizing harm to adjacent healthy tissues. Nanozymes can also be functionalized with specific targeting ligands, allowing for the precise delivery and regulated release of therapeutic agents, improving treatment effectiveness and reducing adverse effects. However, issues such as biocompatibility, selectivity, and regulatory compliance remain critical challenges for the clinical application of nanozymes. This review provides an overview of nanozymes, highlighting their unique properties, various classifications, catalytic activities, and diverse applications in cancer treatments. The strategic oncological deployment of nanozymes could profoundly impact future advancements in personalized medicine, highlighting recent progress and prospective directions in enzyme-mimetic approaches for cancer treatment. This review summarizes an overview of nanozymes, highlighting their unique properties, various classifications, catalytic activities, and diverse applications in cancer treatments.

References

Shen X, Liu W, Gao X, Lu Z, Wu X, Gao X . Mechanisms of Oxidase and Superoxide Dismutation-like Activities of Gold, Silver, Platinum, and Palladium, and Their Alloys: A General Way to the Activation of Molecular Oxygen. J Am Chem Soc. 2015; 137(50):15882-91. DOI: 10.1021/jacs.5b10346. View

Lobenwein D, Kocher F, Dobner S, Gollmann-Tepekoylu C, Holfeld J . Cardiotoxic mechanisms of cancer immunotherapy - A systematic review. Int J Cardiol. 2020; 323:179-187. DOI: 10.1016/j.ijcard.2020.08.033. View

Hu X, Zhang Y, Liu Y, Wang N, Zeng X, Zhang L . Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges. J Nanobiotechnology. 2022; 20(1):437. PMC: 9531473. DOI: 10.1186/s12951-022-01637-w. View

Maji S, Mandal A, Nguyen K, Borah P, Zhao Y . Cancer cell detection and therapeutics using peroxidase-active nanohybrid of gold nanoparticle-loaded mesoporous silica-coated graphene. ACS Appl Mater Interfaces. 2015; 7(18):9807-16. DOI: 10.1021/acsami.5b01758. View

Meng L, Tang L, Gao F, Zhu L, Liu X, Zhang J . Hollow CeO-Based Nanozyme with Self-Accelerated Cascade Reactions for Combined Tumor Therapy. Chemistry. 2024; 30(49):e202401640. DOI: 10.1002/chem.202401640. View

Son S, Kim J, Wang X, Zhang C, Yoon S, Shin J . Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev. 2020; 49(11):3244-3261. DOI: 10.1039/c9cs00648f. View

Zhao R, Zhao X, Gao X . Molecular-level insights into intrinsic peroxidase-like activity of nanocarbon oxides. Chemistry. 2014; 21(3):960-4. DOI: 10.1002/chem.201404647. View

Yi M, Xiong B, Li Y, Guo W, Huang Y, Lu B . Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials. Eur J Med Chem. 2023; 247:115084. DOI: 10.1016/j.ejmech.2022.115084. View

Zhu J, Wang C, Wei Q, Su Y, Qu X, Wang W . PtMo-Au Metalloenzymes Regulated Tumor Microenvironment for Enhanced Sonodynamic/Chemodynamic/Starvation Synergistic Therapy. Small. 2023; 19(45):e2303365. DOI: 10.1002/smll.202303365. View

10.

Zhong Q, Wang K, Pan G, Peng S, Shuai C . Au/CeO Nanozyme Scaffold Boosts Electron and Hydrogen Transfer for NIR-Enhanced Chemodynamic Therapy. ACS Appl Mater Interfaces. 2024; 16(48):65837-65849. DOI: 10.1021/acsami.4c13630. View

11.

Huang Y, Jia L, Zhang S, Yan L, Li L . Bimetallic doped carbon dot nanozymes for enhanced sonodynamic and nanocatalytic therapy. J Mater Chem B. 2024; 13(2):588-598. DOI: 10.1039/d4tb01916d. View

12.

Xu M, Liu Y, Luo W, Tan F, Dong D, Li W . A multifunctional nanocatalytic system based on Chemodynamic-Starvation therapies with enhanced efficacy of cancer treatment. J Colloid Interface Sci. 2022; 630(Pt B):804-816. DOI: 10.1016/j.jcis.2022.10.145. View

13.

Zhang Z, Zeng W, Guo N, Ran M, Gan H, Wu Q . A nanodrug loading indocyanine green and metformin dually alleviating tumor hypoxia for enhanced chemodynamic/sonodynamic therapy. J Colloid Interface Sci. 2024; 680(Pt B):341-355. DOI: 10.1016/j.jcis.2024.11.133. View

14.

Kejik Z, Hajduch J, Abramenko N, Vellieux F, Vesela K, Leischner Fialova J . Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy. Commun Chem. 2024; 7(1):180. PMC: 11322665. DOI: 10.1038/s42004-024-01256-6. View

15.

Zhao H, Zhang R, Yan X, Fan K . Superoxide dismutase nanozymes: an emerging star for anti-oxidation. J Mater Chem B. 2021; 9(35):6939-6957. DOI: 10.1039/d1tb00720c. View

16.

Nygren P . What is cancer chemotherapy?. Acta Oncol. 2001; 40(2-3):166-74. DOI: 10.1080/02841860151116204. View

17.

Niu R, Liu Y, Xu B, Deng R, Zhou S, Cao Y . Programmed Targeting Pyruvate Metabolism Therapy Amplified Single-Atom Nanozyme-Activated Pyroptosis for Immunotherapy. Adv Mater. 2024; 36(24):e2312124. DOI: 10.1002/adma.202312124. View

18.

Wang L, Li S, Zhang X, Huang Y . CoSe hollow microspheres with superior oxidase-like activity for ultrasensitive colorimetric biosensing. Talanta. 2020; 216:121009. DOI: 10.1016/j.talanta.2020.121009. View

19.

Jin Z, Xu G, Niu Y, Ding X, Han Y, Kong W . TiCT MXene-derived TiO/C-QDs as oxidase mimics for the efficient diagnosis of glutathione in human serum. J Mater Chem B. 2020; 8(16):3513-3518. DOI: 10.1039/c9tb02478f. View

20.

Dong Y, Dong S, Liu B, Yu C, Liu J, Yang D . 2D Piezoelectric Bi MoO Nanoribbons for GSH-Enhanced Sonodynamic Therapy. Adv Mater. 2021; 33(51):e2106838. DOI: 10.1002/adma.202106838. View